Tricuspid Regurgitation: Simple Clinical Risk Score For Mortality

Tricuspid Regurgitation: Simple Clinical Risk Score For Mortality

A practical tricuspid regurgitation risk score combines symptoms, imaging, labs, and comorbidities to predict prognosis, guide timely referrals, personalize treatment, and improve patient outcomes.

Arizona’s First Heart Transplant Using ‘Heart In A Box’ Perfusion

Arizona’s first heart-in-a-box transplant showcases warm perfusion technology, extending donor heart preservation, expanding transplant opportunities, improving organ assessment, and offering hope for patients nationwide awaiting.

For patients with nonvalvular atrial fibrillation, a key question has emerged beyond stroke prevention: does our choice of direct oral anticoagulant, or DOAC, influence long-term dementia risk? A landmark study provides a clear answer.

New baby food rules require public testing for lead, arsenic, cadmium, and mercury, improving transparency, guiding safer choices, and encouraging manufacturers to reduce contamination.

Direct Oral Anticoagulants and Dementia Risk in Nonvalvular Atrial Fibrillation: Evidence to Guide Clinical Selection

Large real-world study found no meaningful dementia risk differences between apixaban, edoxaban, and rivaroxaban, supporting DOAC selection based on safety, adherence, renal function, and patient needs.

Direct Oral Anticoagulants and Dementia Risk in Nonvalvular Atrial Fibrillation: Evidence to Guide Clinical Selection

Large real-world study found apixaban, edoxaban, and rivaroxaban offer similar dementia protection in atrial fibrillation, allowing clinicians to prioritize safety, adherence, and patient-specific factors.